Bulletin
Investor Alert

New York Markets Open in:

Merck & Co. Inc.

NYS: MRK

GO
/marketstate/country/us

After Hours

MRK
/zigman2/quotes/209956077/composite

$

103.88

Change

0.00 0.00%

Volume

Volume 1.66m

Dec 7, 2023, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209956077/composite

Previous close

$ 105.63

$ 103.88

Change

-1.75 -1.66%

Day low

Day high

$103.73

$105.60

Open
Open: 105.59

52 week low

52 week high

$99.14

$119.65

Open

Market cap

$267.67B

Average volume

7.70M

P/E ratio

57.70

Rev. per Employee

$842,667

EPS

1.80

Dividend

0.77

Div yield

2.96%

Ex dividend date

12/14/23

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mrk

MarketWatch News on MRK

  1. Merck & Co.’s stock falls 1.6% as biggest decliner in Dow Jones Industrial Average

    9:54 a.m. Dec. 7, 2023

    - Steve Gelsi

  2. Merck raises quarterly dividend to 77 cents vs. 73 cents

    1:23 p.m. Nov. 28, 2023

    - Ciara Linnane

  3. A Golden Age of Vaccines Is Here. What It Means for You.

    3:20 p.m. Nov. 21, 2023

    - Neal Templin

  4. Merck paying $610 million for Caraway Therapeutics

    7:13 a.m. Nov. 21, 2023

    - Steve Gelsi

  5. Grab these 2 funds with rich 11%-12% yields while you can

    11:35 a.m. Nov. 11, 2023

    - Michael Brush

  6. Merck started at buy with $115 stock price target at Deutsche Bank

    10:22 a.m. Nov. 9, 2023

    - Tomi Kilgore

  7. Pharma Stocks Are Bleeding. 2 Look Like Bargains.

    10:51 a.m. Nov. 6, 2023

    - Josh Nathan-Kazis

  8. Moderna Reports Big Loss in Post-Pandemic Reset

    6:30 a.m. Nov. 2, 2023

    - Josh Nathan-Kazis

  9. Drug Stocks Keep Tanking on Earnings. Brace for More.

    11:08 a.m. Oct. 30, 2023

    - Josh Nathan-Kazis

  10. Merck upgraded to outperform at BMO Capital

    10:37 a.m. Oct. 27, 2023

    - Tomi Kilgore

  11. Merck Raises Sales Outlook After Earnings Beat

    6:48 a.m. Oct. 26, 2023

    - Josh Nathan-Kazis

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/mrk

Other News on MRK

  1. Merck Scraps Phase 3 Keytruda-Lynparza Lung Cancer Study

    8:04 a.m. Dec. 7, 2023

    - The Wall Street Journal Interactive Edition

  2. The Stocks That AI Mania Left Behind

    2:32 a.m. Nov. 29, 2023

    - The Wall Street Journal Interactive Edition

  3. Earnings Estimates Are Falling. These Two Companies Are Shouldering the Blame.

    2:32 a.m. Nov. 15, 2023

    - The Wall Street Journal Interactive Edition

  4. ‘Guided Missile Drugs’ Could Be Big Pharma’s Secret Weapon

    1:32 a.m. Oct. 27, 2023

    - The Wall Street Journal Interactive Edition

  5. These Are the Two Scientists Taking Down Cold Medicines That Don’t Work

    1:52 p.m. Oct. 21, 2023

    - The Wall Street Journal Interactive Edition

  6. Merck, Daiichi Sankyo Ink Commercialization Deal for Up to $22 Billion

    9:29 p.m. Oct. 19, 2023

    - The Wall Street Journal Interactive Edition

  7. How Research in Space Helps Doctors Treat People on Earth

    12:01 p.m. Sept. 27, 2023

    - The Wall Street Journal Interactive Edition

  8. Big Pharma’s Battle With the Biden Administration Could Have Legs

    8:46 a.m. Sept. 13, 2023

    - The Wall Street Journal Interactive Edition

  9. How Novartis’s CEO Learned From Mistakes and Got Help From an Unlikely Quarter

    1:33 a.m. Sept. 5, 2023

    - The Wall Street Journal Interactive Edition

  10. Expensive Drugs Targeted for First U.S. Price Negotiations

    2:40 p.m. Oct. 10, 2023

    - The Wall Street Journal Interactive Edition

  11. Get In on This Skin Disease Drug Before Big Pharma Does

    2:34 p.m. Aug. 21, 2023

    - The Wall Street Journal Interactive Edition

  12. Stocks for the Short Run

    2:50 p.m. Aug. 8, 2023

    - The Wall Street Journal Interactive Edition

  13. Apple, Amazon, Starbucks to Report in Packed Earnings Week

    12:43 p.m. Aug. 1, 2023

    - The Wall Street Journal Interactive Edition

  14. Big Pharma Bets Big on China

    3:43 p.m. July 27, 2023

    - The Wall Street Journal Interactive Edition

  15. Companies Brace for Supreme Court Ruling on Affirmative Action

    11:04 p.m. June 26, 2023

    - The Wall Street Journal Interactive Edition

  16. Chamber of Commerce Challenges Government’s Drug-Price Powers

    7:47 a.m. Aug. 29, 2023

    - The Wall Street Journal Interactive Edition

  17. Merck Sues to Stop the IRA’s ‘Extortion’

    3:26 p.m. June 8, 2023

    - The Wall Street Journal Interactive Edition

  18. Merck Challenges U.S. Government’s New Powers to Negotiate Drug Prices

    7:49 a.m. Aug. 29, 2023

    - The Wall Street Journal Interactive Edition

  19. Top Morgan Stanley M&A Banker to Join Law Firm Paul Weiss

    8:20 a.m. June 7, 2023

    - The Wall Street Journal Interactive Edition

  20. New Pfizer RSV Vaccine Rolls Out Into Headwinds of Hesitancy

    1:35 a.m. June 1, 2023

    - The Wall Street Journal Interactive Edition

  21. Loading more headlines...

Rates »

Link to MarketWatch's Slice.